In Vitro and In Vivo Assessment of Intraintestinal Bacteriotherapy in Chronic Kidney Disease

No abstract is available for this paper.

• Publication year

  2006

• Venue

  ASAIO journal (1992)

• Publication date

  2006-01-01

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.1097/01.mat.0000191345.45735.00PMID 16436893
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• THE EFFECT OF ENVIRONMENT ON KIBOW BIOTICS?? DURING INTERNATIONAL TRAVEL

  2006cited by this paper
• Ammonium assimilation in Proteus vulgaris, Bacillus pasteurii, and Sporosarcina ureae

  2004cited by this paper
• Survival of hemodialysis patients and uremic toxin removal.

  2003cited by this paper
• Bifidobacterium in gastro-resistant seamless capsule reduces serum levels of indoxyl sulfate in patients on hemodialysis.

  2003cited by this paper
• ARTIFICIAL SWALLOWABLE KIDNEY FORMULATION

  2003cited by this paper
• Review on uremic toxins: classification, concentration, and interindividual variability.

  2003cited by this paper
• clinical practice guidelines for chronic kidney disease : evaluation, classification, and stratification

  2002cited by this paper
• K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.

  2002cited by this paper
• Urea kinetic modelling: a measure of dialysis adequacy

  2001cited by this paper
• In vitro selection criteria for probiotic bacteria of human origin: correlation with in vivo findings.

  2001cited by this paper
• Uremic toxins: new aspects.

  2000cited by this paper
• Fermentation by gut microbiota cultured in a simulator of the human intestinal microbial ecosystem is improved by supplementing a soygerm powder.

  2000cited by this paper
• Effect of ammonia on the growth of Bacillus species and some other bacteria

  2000cited by this paper
• Pathophysiologic effects of uremic retention solutes.

  1999cited by this paper
• Urea-associated oxidative stress and Gadd153/CHOP induction.

  1999cited by this paper
• The effect of consumption of milk fermented by Lactobacillus casei strain Shirota on the intestinal microflora and immune parameters in humans

  1998cited by this paper
• Microencapsulated genetically engineered live E. coli DH5 cells administered orally to maintain normal plasma urea level in uremic rats

  1996cited by this paper
• Inhibition of the accumulation of uremic toxins in the blood and their precursors in the feces after oral administration of Lebenin, a lactic acid bacteria preparation, to uremic patients undergoing hemodialysis.

  1996cited by this paper
• Ammonium/urea-dependent generation of a proton electrochemical potential and synthesis of ATP in Bacillus pasteurii

  1996cited by this paper
• Preparation and in vitro analysis of microencapsulated genetically engineered E. coli DH5 cells for urea and ammonia removal

  1995cited by this paper
• Factors determining hemoglobin carbamylation in renal failure.

  1995cited by this paper
• Metabolic significance of the colonic microflora

  1995cited by this paper
• Copyright � 1995, American Society for Microbiology Molecular Biology of Microbial Ureases

  1995cited by this paper
• Validation of the Simulator of the Human Intestinal Microbial Ecosystem (SHIME) Reactor Using Microorganism-associated Activities

  1994cited by this paper
• The control and consequences of bacterial fermentation in the human colon.

  1991cited by this paper
• Microbial ureases: significance, regulation, and molecular characterization.

  1989cited by this paper
• Solubility of uric acid and supersaturation of monosodium urate: why is uric acid so highly soluble in urine?

  1989cited by this paper
• Evidence for carrier-mediated, energy-dependent uptake of urea in some bacteria

  1988cited by this paper
• Short chain fatty acids in human large intestine, portal, hepatic and venous blood.

  1987cited by this paper
• Protein degradation by human intestinal bacteria.

  1986cited by this paper
• Determinants of ureagenesis, with particular reference to renal failure.

  1980cited by this paper
• Review of gastrointestinal perfusion in the treatment of uremia.

  1979cited by this paper
• Review of gastrointestinal perfusion in the treatment of uremia.

  1979cited by this paper
• Gastrosorbents in the therapy of uremia: inferences from intestinal loop dialysis.

  1975cited by this paper
• Gastrosorbents in the therapy of uremia: inferences from intestinal loop dialysis.

  1975cited by this paper
• Effects of urea loading in patients with far-advanced renal failure.

  1972cited by this paper
• Studies on the intestinal flora. I. The bacterial flora of the gastrointestinal tract in healthy and achlorhydric persons.

  1969cited by this paper
• Rapid determination of urea nitrogen in serum or plasma without deproteinization.

  1967cited by this paper
• Rapid determination of urea nitrogen in serum or plasma without deproteinization.

  1967cited by this paper
• AUTOMATED AND MANUAL DIRECT METHODS FOR THE DETERMINATION OF BLOOD UREA.

  1965cited by this paper
• PURIFICATION AND PROPERTIES OF BACTERIAL UREASE

  1954cited by this paper
• Histochemistry of Whipple's disease.

  1954cited by this paper

• Fexuprazan mitigates NSAID-induced small intestinal injury by restoring intestinal barrier integrity in mice.

  2025cites this paper
• Lacticaseibacillus rhamnosus attenuates uremic toxins in patients with nondialysis chronic kidney disease through the anti-inflammatory molecules

  2025cites this paper
• EFFECTS OF CLOSTRIDIUM BUTYRICUM SUPPLEMENTATION ON FECAL MICROBIOTA AND METABOLITES IN CAPTIVE RED KANGAROO (MACROPUS RUFUS)

  2025cites this paper
• Gut bacteria: an etiological agent in human pathological conditions

  2024cites this paper
• Protective Effect of Bifidobacterium longum and Streptococcus thermophilus against Simvastatin-Induced Rhabdomyolysis in Hypercholesteraemic Rats

  2024cites this paper
• A new generation of mesenchymal stromal/stem cells differentially trained by immunoregulatory probiotics in a lupus microenvironment

  2023cites this paper
• Oral administration of vancomycin alleviates heart failure triggered by chronic kidney disease.

  2023cites this paper
• Regulation of gut microbiota: a novel pretreatment for complications in patients who have undergone kidney transplantation

  2023cites this paper
• The ameliorating effect of limosilactobacillus fermentum and its supernatant postbiotic on cisplatin-induced chronic kidney disease in an animal model

  2023cites this paper
• Microbial-Derived Tryptophan Catabolites, Kidney Disease and Gut Inflammation

  2022cites this paper
• The Effects of Sacran, a Sulfated Polysaccharide, on Gut Microbiota Using Chronic Kidney Disease Model Rats.

  2022cites this paper
• Lactobacillus rhamnosus L34 attenuates chronic kidney disease progression in 5/6 nephrectomy mouse model through the excretion of anti-inflammatory molecules.

  2022cites this paper
• Are Probiotics Needed in Nephrology?

  2022cites this paper
• Evaluation of the effectiveness of two new strains of Lactobacillus on obesity-induced kidney diseases in BALB/c mice

  2022cites this paper
• Effectiveness of new selenium-enriched mutated probiotics in reducing inflammatory effects of piroxicam medication in liver and kidney

  2022cites this paper
• Clostridium butyricum affects nutrition and immunology by modulating gut microbiota

  2021cites this paper
• Probiotics and Prebiotics in Chronic Kidney Disease

  2021cites this paper
• Effect of a Probiotic Combination in an Experimental Mouse Model and Clinical Patients With Chronic Kidney Disease: A Pilot Study

  2021cites this paper
• Biotic Supplements in Patients With Chronic Kidney Disease: Meta-Analysis of Randomized Controlled Trials.

  2021cites this paper
• Pilot Study of Probiotic Supplementation on Uremic Toxicity and Inflammatory Cytokines in Chronic Kidney Patients

  2020cites this paper
• Management of Advanced Stages of Chronic Kidney Disease Patients with the Administration of Renadyl Capsule: A Single Center Pilot Study in Bangladesh

  2020cites this paper
• Gut Microbial Changes in Diabetic db/db Mice and Recovery of Microbial Diversity upon Pirfenidone Treatment

  2020cites this paper
• Intestinal microbiota alterations in chronic kidney disease and the influence of dietary components

  2020influential citation
• Gut microbiota and chronic kidney disease: evidences and mechanisms that mediate a new communication in the gastrointestinal-renal axis

  2020cites this paper
• Impact of Gut Dysbiosis on Neurohormonal Pathways in Chronic Kidney Disease

  2019cites this paper
• Therapeutic Prospective of a Spore-Forming Probiotic—Bacillus clausii UBBC07 Against Acetaminophen-Induced Uremia in Rats

  2019cites this paper
• Inflammation in Renal Diseases: New and Old Players

  2019cites this paper
• Impact of Gut Microbiota Composition on Onset and Progression of Chronic Non-Communicable Diseases

  2019cites this paper
• Probiotic Supplementation in Chronic Kidney Disease: A Double-blind, Randomized, Placebo-controlled Trial.

  2018cites this paper
• Urea and chronic kidney disease: the comeback of the century? (in uraemia research)

  2018cites this paper
• Gut microbiota and chronic kidney disease: implications for novel mechanistic insights and therapeutic strategies

  2018cites this paper
• Effects of Probiotics on Inflammation and Uremic Toxins Among Patients on Dialysis: A Systematic Review and Meta-Analysis

  2018cites this paper
• Inflammation-Related Mechanisms in Chronic Kidney Disease Prediction, Progression, and Outcome

  2018cites this paper
• The effects of probiotics on renal function and uremic toxins in patients with chronic kidney disease; a meta-analysis of randomized controlled trials

  2018cites this paper
• Reality of "Enteric Dialysis ®" with Probiotics and Prebiotics to Delay the Need of Conventional Dialysis

  2018influential citation
• Effect of Different Lebanese Probiotics on the Growth and Some Biochemical Parameters of the Experimental Rats

  2018cites this paper
• “Enteric Dialysis®” – From Concept to Reality [In conjunction with standard care of therapy]

  2018cites this paper
• Full Reviews Urea and chronic kidney disease: the comeback of the century? (in uraemia research)

  2018cites this paper
• The role of the gastrointestinal tract and microbiota on uremic toxins and chronic kidney disease development

  2017cites this paper
• Use of probiotics in small animal veterinary medicine.

  2017cites this paper
• The gut‐kidney axis in chronic renal failure: A new potential target for therapy

  2017cites this paper
• Gut microbiota and renal transplant outcome.

  2017cites this paper
• p-Cresyl Sulfate

  2017cites this paper
• Effects of Akkermansia muciniphila Supplementation on Markers of Intestinal Permeability in Dogs Following Antibiotic Treatment

  2017cites this paper
• Depletion of Gut Microbiota Protects against Renal Ischemia-Reperfusion Injury.

  2017cites this paper
• Innovations in Kidney Transplant Research

  2017cites this paper
• Mechanism and Applications of Bio-mineralization Induced by Sporosarcina pasteurii and Related Microorganisms

  2017cites this paper
• Gut Lactobacillus protects against the progression of renal damage by modulating the gut environment in rats.

  2016cites this paper
• Gut Microbiome and Kidney Disease in Pediatrics: Does Connection Exist?

  2016cites this paper
• Gut microbiota in renal physiology: focus on short-chain fatty acids and their receptors.

  2016cites this paper
• Fecal Matter Implantation as a Way to Fight Diarrhea-Causing Microorganisms

  2016cites this paper
• Current status of the microbiome in renal transplantation

  2016cites this paper
• Synbiotic Supplementations for Azotemia in Patients With Chronic Kidney Disease: a Randomized Controlled Trial.

  2016cites this paper
• Characterization of ureolytic bacteria isolated from limestone caves of Sarawak and evaluation of their efficiency in biocementation

  2016cites this paper
• The Role of the Gut Microbiome on Chronic Kidney Disease.

  2016cites this paper
• The effect of probiotics on serum levels of cytokine and endotoxin in peritoneal dialysis patients: a randomised, double-blind, placebo-controlled trial.

  2015cites this paper
• Probiotics and chronic kidney disease.

  2015cites this paper
• The Role of Integrated Omics in Elucidating the Gut Microbiota Health Potentials

  2015cites this paper
• The intestine and the kidneys: a bad marriage can be hazardous

  2015cites this paper
• Probiotic dietary supplementation in a dog with chronic kidney disease

  2014influential citation
• Azotemia and Uremia

  2014cites this paper
• Therapeutic effect of Streptococcus thermophilus (MTCC 1938) on acetaminophen induced uremia in experimental rats

  2014cites this paper
• INTERNATIONAL JOURNAL OF MEDICAL AND APPLIED SCIENCES

  2014cites this paper
• The Family Planococcaceae

  2014cites this paper
• Protective effect of selected urease positive Lactobacillus strains on acetaminophen induced uremia in rats

  2014cites this paper
• Protein-Bound Uremic Toxins: New Culprits of Cardiovascular Events in Chronic Kidney Disease Patients

  2014cites this paper
• Toward the comprehensive understanding of the gut ecosystem via metabolomics-based integrated omics approach

  2014cites this paper
• Lactobacillus bulgaricus mutants decompose uremic toxins

  2014cites this paper
• Intestinal Microbiota-Kidney Cross Talk in Acute Kidney Injury and Chronic Kidney Disease

  2014cites this paper
• Cloning and Expression of a Urate Oxidase and Creatinine Hydrolase Fusion Gene in Escherichia coli

  2013cites this paper
• Effect of newly isolated Lactobacillus ingluviei ADK10, from chicken intestinal tract on acetaminophen induced oxidative stress in Wistar rats.

  2013cites this paper
• Therapeutic potential of Lactobacillus ingluviei ADK10, a newly established probiotic organism against acetaminophen induced uremic rats

  2013influential citation
• Dose Escalation, Safety and Impact of a Strain-Specific Probiotic (Renadyl™) on Stages III and IV Chronic Kidney Disease Patients

  2013cites this paper
• Clinical and experimental use of probiotic formulations for management of end-stage renal disease: an update

  2013cites this paper
• The intestinal microbiota, a leaky gut, and abnormal immunity in kidney disease.

  2013cites this paper
• In vivo assessment of bacteriotherapy on acetaminophen-induced uremic rats.

  2013cites this paper
• Assessment of efficacy of a potential probiotic strain and its antiuremic and antioxidative activities

  2013cites this paper
• Dialysis Free Protocol for Some End Stage Renal Disease Patients (Khosroshahi Protocol)

  2012cites this paper
• New paradigms for the use of prebiotics, probiotics, and synbiotics in renal disease

  2011cites this paper
• Intestinal-Renal Syndrome: Mirage or Reality?

  2011cites this paper
• The use of probiotics as dietary supplements in dogs

  2011cites this paper
• Azodyl, a synbiotic, fails to alter azotemia in cats with chronic kidney disease when sprinkled onto food

  2011cites this paper
• Gut flora may offer new therapeutic targets for the traditional Chinese medicine enteric dialysis

  2011cites this paper
• The Effects of a Probiotic on Blood Urea Nitrogen and Creatinine Concentrations in Large Felids

  2011cites this paper
• Pilot study of probiotic dietary supplementation for promoting healthy kidney function in patients with chronic kidney disease

  2010cites this paper
• Warfarin therapy in patients with venous thromboembolism: Patterns of use and predictors of clinical outcomes

  2010cites this paper
• The Gut: The Forgotten Organ in Uremia?

  2010cites this paper
• Probiotic dietary supplementation in patients with stage 3 and 4 chronic kidney disease: a 6-month pilot scale trial in Canada

  2009cites this paper
• Probiotics in veterinary practice.

  2009cites this paper
• Arabinoxylan‐oligosaccharides (AXOS) affect the protein/carbohydrate fermentation balance and microbial population dynamics of the Simulator of Human Intestinal Microbial Ecosystem

  2008cites this paper
• Intestinal bacterial microflora--a potential source of chronic inflammation in patients with chronic kidney disease.

  2006cites this paper
• Nephrotoxicity of ciclosporin A: short-term gain, long-term pain?

  2006cites this paper
• Clinical Study Randomized Controlled Trial of Strain-specific Probiotic Formulation (renadyl) in Dialysis Patients

  year unknowncites this paper
• World Journal of Nephrology

  year unknowncites this paper
• World Journal of Nephrology

  year unknowncites this paper